From APICES, we are privileged to share the acknowledgment that we have received in the recent publication titled “Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial” published in Radiotherapy and Oncology.
We would like again to thank Almudena Zapatero and GICOR group for the opportunity to be appeared on this study as authors and also in the acknowledgements of the publication as well as congratulating them on the success of the project.
This means an extra motivation to all APICES team in order to give continuity to the implication we have in every project in which we collaborate.
The publication discusses the results of a phase III prostate cancer treatment trial which aims is to evaluate the effect of serum testosterone levels on clinical outcome in localized prostate cancer treated with androgen deprivation therapy and high-dose radiotherapy.
You can find the publication in the following link: